Click for best price
Antiparasitic Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Antiparasitic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiparasitic Drugs. This report contains market size and forecasts of Antiparasitic Drugs in global, including the following market information:
Global Antiparasitic Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Antiparasitic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
by Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antiparasitic Drugs include Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG and Alvizia Health Care, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiparasitic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiparasitic Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Antiparasitic Drugs Market Segment Percentages, by Type, 2022 (%)
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Global Antiparasitic Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Antiparasitic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Antiparasitic Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Antiparasitic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiparasitic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antiparasitic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiparasitic Drugs, market overview.
Chapter 2: Global Antiparasitic Drugs market size in revenue.
Chapter 3: Detailed analysis of Antiparasitic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiparasitic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antiparasitic Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiparasitic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiparasitic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiparasitic Drugs Overall Market Size
2.1 Global Antiparasitic Drugs Market Size: 2022 VS 2032
2.2 Global Antiparasitic Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiparasitic Drugs Players in Global Market
3.2 Top Global Antiparasitic Drugs Companies Ranked by Revenue
3.3 Global Antiparasitic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antiparasitic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiparasitic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiparasitic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Antiparasitic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiparasitic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiparasitic Drugs Market Size Markets, 2022 & 2032
4.1.2 Anthelmintics
4.1.3 Antiprotozoals
4.1.4 Others
4.2 By Type - Global Antiparasitic Drugs Revenue & Forecasts
4.2.1 By Type - Global Antiparasitic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Antiparasitic Drugs Revenue, 2024-2032
4.2.3 By Type - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiparasitic Drugs Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Antiparasitic Drugs Revenue & Forecasts
5.2.1 By Application - Global Antiparasitic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Antiparasitic Drugs Revenue, 2024-2032
5.2.3 By Application - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Antiparasitic Drugs Market Size, 2022 & 2032
6.2 By Region - Global Antiparasitic Drugs Revenue & Forecasts
6.2.1 By Region - Global Antiparasitic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Antiparasitic Drugs Revenue, 2024-2032
6.2.3 By Region - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Antiparasitic Drugs Revenue, 2018-2032
6.3.2 US Antiparasitic Drugs Market Size, 2018-2032
6.3.3 Canada Antiparasitic Drugs Market Size, 2018-2032
6.3.4 Mexico Antiparasitic Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Antiparasitic Drugs Revenue, 2018-2032
6.4.2 Germany Antiparasitic Drugs Market Size, 2018-2032
6.4.3 France Antiparasitic Drugs Market Size, 2018-2032
6.4.4 U.K. Antiparasitic Drugs Market Size, 2018-2032
6.4.5 Italy Antiparasitic Drugs Market Size, 2018-2032
6.4.6 Russia Antiparasitic Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Antiparasitic Drugs Market Size, 2018-2032
6.4.8 Benelux Antiparasitic Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Antiparasitic Drugs Revenue, 2018-2032
6.5.2 China Antiparasitic Drugs Market Size, 2018-2032
6.5.3 Japan Antiparasitic Drugs Market Size, 2018-2032
6.5.4 South Korea Antiparasitic Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Antiparasitic Drugs Market Size, 2018-2032
6.5.6 India Antiparasitic Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Antiparasitic Drugs Revenue, 2018-2032
6.6.2 Brazil Antiparasitic Drugs Market Size, 2018-2032
6.6.3 Argentina Antiparasitic Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiparasitic Drugs Revenue, 2018-2032
6.7.2 Turkey Antiparasitic Drugs Market Size, 2018-2032
6.7.3 Israel Antiparasitic Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Antiparasitic Drugs Market Size, 2018-2032
6.7.5 UAE Antiparasitic Drugs Market Size, 2018-2032
7 Antiparasitic Drugs Companies Profiles
7.1 Ipca Laboratories Ltd
7.1.1 Ipca Laboratories Ltd Company Summary
7.1.2 Ipca Laboratories Ltd Business Overview
7.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Major Product Offerings
7.1.4 Ipca Laboratories Ltd Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.1.5 Ipca Laboratories Ltd Key News & Latest Developments
7.2 Zydus Cadila
7.2.1 Zydus Cadila Company Summary
7.2.2 Zydus Cadila Business Overview
7.2.3 Zydus Cadila Antiparasitic Drugs Major Product Offerings
7.2.4 Zydus Cadila Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.2.5 Zydus Cadila Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Antiparasitic Drugs Major Product Offerings
7.3.4 Merck Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Antiparasitic Drugs Major Product Offerings
7.4.4 Pfizer Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Company Summary
7.5.2 GlaxoSmithKline Plc. Business Overview
7.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Plc. Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.6 Cipla Ltd
7.6.1 Cipla Ltd Company Summary
7.6.2 Cipla Ltd Business Overview
7.6.3 Cipla Ltd Antiparasitic Drugs Major Product Offerings
7.6.4 Cipla Ltd Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.6.5 Cipla Ltd Key News & Latest Developments
7.7 Ranbaxy Laboratories
7.7.1 Ranbaxy Laboratories Company Summary
7.7.2 Ranbaxy Laboratories Business Overview
7.7.3 Ranbaxy Laboratories Antiparasitic Drugs Major Product Offerings
7.7.4 Ranbaxy Laboratories Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.7.5 Ranbaxy Laboratories Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Antiparasitic Drugs Major Product Offerings
7.8.4 Novartis AG Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Alvizia Health Care
7.9.1 Alvizia Health Care Company Summary
7.9.2 Alvizia Health Care Business Overview
7.9.3 Alvizia Health Care Antiparasitic Drugs Major Product Offerings
7.9.4 Alvizia Health Care Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.9.5 Alvizia Health Care Key News & Latest Developments
7.10 Bayer AG
7.10.1 Bayer AG Company Summary
7.10.2 Bayer AG Business Overview
7.10.3 Bayer AG Antiparasitic Drugs Major Product Offerings
7.10.4 Bayer AG Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.10.5 Bayer AG Key News & Latest Developments
7.11 Roche Inc
7.11.1 Roche Inc Company Summary
7.11.2 Roche Inc Business Overview
7.11.3 Roche Inc Antiparasitic Drugs Major Product Offerings
7.11.4 Roche Inc Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.11.5 Roche Inc Key News & Latest Developments
7.12 Arbor Pharmaceuticals Inc.
7.12.1 Arbor Pharmaceuticals Inc. Company Summary
7.12.2 Arbor Pharmaceuticals Inc. Business Overview
7.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Major Product Offerings
7.12.4 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.12.5 Arbor Pharmaceuticals Inc. Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Antiparasitic Drugs Major Product Offerings
7.13.4 Sanofi Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 AstraZeneca
7.14.1 AstraZeneca Company Summary
7.14.2 AstraZeneca Business Overview
7.14.3 AstraZeneca Antiparasitic Drugs Major Product Offerings
7.14.4 AstraZeneca Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.14.5 AstraZeneca Key News & Latest Developments
7.15 Alkem Laboratories Limited
7.15.1 Alkem Laboratories Limited Company Summary
7.15.2 Alkem Laboratories Limited Business Overview
7.15.3 Alkem Laboratories Limited Antiparasitic Drugs Major Product Offerings
7.15.4 Alkem Laboratories Limited Antiparasitic Drugs Revenue in Global Market (2018-2023)
7.15.5 Alkem Laboratories Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiparasitic Drugs Market Opportunities & Trends in Global Market
Table 2. Antiparasitic Drugs Market Drivers in Global Market
Table 3. Antiparasitic Drugs Market Restraints in Global Market
Table 4. Key Players of Antiparasitic Drugs in Global Market
Table 5. Top Antiparasitic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiparasitic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiparasitic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiparasitic Drugs Product Type
Table 9. List of Global Tier 1 Antiparasitic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiparasitic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antiparasitic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Antiparasitic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiparasitic Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Antiparasitic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Antiparasitic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiparasitic Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Antiparasitic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Antiparasitic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiparasitic Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Antiparasitic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiparasitic Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Antiparasitic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiparasitic Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Antiparasitic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiparasitic Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Antiparasitic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiparasitic Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Antiparasitic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiparasitic Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Ipca Laboratories Ltd Company Summary
Table 31. Ipca Laboratories Ltd Antiparasitic Drugs Product Offerings
Table 32. Ipca Laboratories Ltd Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Ipca Laboratories Ltd Key News & Latest Developments
Table 34. Zydus Cadila Company Summary
Table 35. Zydus Cadila Antiparasitic Drugs Product Offerings
Table 36. Zydus Cadila Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Zydus Cadila Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Antiparasitic Drugs Product Offerings
Table 40. Merck Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Antiparasitic Drugs Product Offerings
Table 44. Pfizer Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. GlaxoSmithKline Plc. Company Summary
Table 47. GlaxoSmithKline Plc. Antiparasitic Drugs Product Offerings
Table 48. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Plc. Key News & Latest Developments
Table 50. Cipla Ltd Company Summary
Table 51. Cipla Ltd Antiparasitic Drugs Product Offerings
Table 52. Cipla Ltd Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Cipla Ltd Key News & Latest Developments
Table 54. Ranbaxy Laboratories Company Summary
Table 55. Ranbaxy Laboratories Antiparasitic Drugs Product Offerings
Table 56. Ranbaxy Laboratories Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Ranbaxy Laboratories Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Antiparasitic Drugs Product Offerings
Table 60. Novartis AG Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Alvizia Health Care Company Summary
Table 63. Alvizia Health Care Antiparasitic Drugs Product Offerings
Table 64. Alvizia Health Care Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Alvizia Health Care Key News & Latest Developments
Table 66. Bayer AG Company Summary
Table 67. Bayer AG Antiparasitic Drugs Product Offerings
Table 68. Bayer AG Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer AG Key News & Latest Developments
Table 70. Roche Inc Company Summary
Table 71. Roche Inc Antiparasitic Drugs Product Offerings
Table 72. Roche Inc Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Inc Key News & Latest Developments
Table 74. Arbor Pharmaceuticals Inc. Company Summary
Table 75. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product Offerings
Table 76. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Arbor Pharmaceuticals Inc. Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Antiparasitic Drugs Product Offerings
Table 80. Sanofi Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. AstraZeneca Company Summary
Table 83. AstraZeneca Antiparasitic Drugs Product Offerings
Table 84. AstraZeneca Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. AstraZeneca Key News & Latest Developments
Table 86. Alkem Laboratories Limited Company Summary
Table 87. Alkem Laboratories Limited Antiparasitic Drugs Product Offerings
Table 88. Alkem Laboratories Limited Antiparasitic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Alkem Laboratories Limited Key News & Latest Developments
List of Figures
Figure 1. Antiparasitic Drugs Segment by Type in 2022
Figure 2. Antiparasitic Drugs Segment by Application in 2022
Figure 3. Global Antiparasitic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiparasitic Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Antiparasitic Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2022
Figure 8. By Type - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Antiparasitic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Antiparasitic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 16. US Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 28. China Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Antiparasitic Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Antiparasitic Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Ipca Laboratories Ltd Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Zydus Cadila Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cipla Ltd Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ranbaxy Laboratories Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Alvizia Health Care Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer AG Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Inc Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sanofi Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. AstraZeneca Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Alkem Laboratories Limited Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
